GlassScriptPhysician profile
Amanda Jane Setto
NPI 1073082335
$2,357.06
in general payments reported to CMS, 2019-2025
11 companies · $632 in 2025
The $632 reported for 2025 was more than what 83% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.15 · 2020: $130 · 2022: $159 · 2023: $675 · 2024: $736 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,044.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,043.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $782.66 | 2022-2025 | Cequa |
| Alcon Vision LLC | $418.60 | 2024-2025 | Eysuvis, Rocklatan, Tryptyr |
| Bausch & Lomb Americas INC. | $292.02 | 2023-2024 | Miebo, Xiidra |
| Tarsus Pharmaceuticals, INC. | $226.73 | 2024-2025 | Xdemvy |
| Thea Pharma INC. | $186.29 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $147.20 | 2024-2025 | Acuvue |
| Dompe US, INC. | $123.22 | 2023 | Oxervate |
| Sight Sciences, INC. | $113.17 | 2020 | |
| Novartis Pharmaceuticals Corporation | $25.78 | 2023 | |
| Roche Diagnostics Corporation | $24.15 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Setto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.